Claritas Rx wins Fierce AI Innovation Award for Omnichannel Engagement Strategy. E-mail Address StreetInsider.com Top Tickers, 9/2/2026 September 2, 2026 11:37 AM EDT Patient Watchtower(TM) and Patient Services Omnichannel CRM Recognized for Turning Predictive Signals Into Coordinated Action Across the Patient Journey SOUTH SAN FRANCISCO, Calif.-(BUSINESS WIRE)- Claritas Rx, the patient journey experts, today announced it has won the Fierce AI Innovation Award in the Omnichannel Engagement Strategy category. The award recognizes Patient Watchtower(TM) and the Patient Services Omnichannel CRM - two connected AI-powered solutions that let biopharma manufacturers spot risk earlier in the patient journey and coordinate real-time action across every partner helping patients start and stay on therapy. Claritas Rx wins Fierce AI Innovation Award for Omnichannel Engagement Strategy. Patient Watchtower(TM) and Patient Services Omnichannel CRM recognized for turning predictive signals into coordinated action across the patient journey. For patients prescribed specialty and rare disease therapies, the path from prescription to treatment is fragile. Between 31% and 40% of specialty prescriptions go unfilled, and patients whose fill takes longer than 30 days convert at a rate 18 percentage points lower than those who fill sooner. Along the way, a single patient may touch a hub, a specialty pharmacy, a payer, and a copay program within days of each other, each generating data that, on its own, tells only part of the story. Historically, patient services teams have had to wait for a missed fill or a lapsed authorization to signal that a patient had already fallen off therapy. Patient Watchtower and the Patient Services Omnichannel CRM close that gap by connecting prediction to action at every stage of the journey. Patient Watchtower uses AI and machine learning to predict therapy discontinuation, prior authorization denial, and prescription abandonment up to 90 days in advance, with up to 80% precision. The moment a patient is flagged, the Patient Services Omnichannel CRM helps turns that signal into coordinated outreach, connecting case managers, hub partners, and specialty pharmacies in a single workflow so the right partner can respond before a patient drops off therapy. "Every stage of the patient journey generates a signal, but most teams don't see it until it's too late," said Michael Fitzgibbons, CEO of Claritas Rx. "This award reflects work that's built entirely around closing that gap - connecting the moment we detect risk to the moment someone acts on it, so patients start and stay on the therapies they need. That's the promise we make on every patient journey, and it's an honor to see our innovation recognized by Fierce and the industry." Since launching, Patient Watchtower and the Patient Services Omnichannel CRM have delivered measurable results across the patient journey, including a 20% improvement in fill rates, 17% increase in refill rates, a 98% partner response rate within 24 hours, and a significant reduction in manual case management burden - freeing patient services teams to focus on direct patient care rather than administrative reconciliation. The Fierce AI Innovation Awards, presented by Fierce Life Sciences, recognize organizations that are moving beyond AI pilots to deliver measurable impact across the biotech, pharma, and healthcare value chain, from R&D and clinical trials to commercialization, manufacturing, and care delivery. Entries were evaluated on innovation, impact, execution, scalability, and industry relevance. Winners were announced in Fierce Life Sciences' September 2 Special Report. About Claritas Rx Based in South San Francisco, CA, Claritas Rx helps rare disease and specialty brands remove the barriers that keep patients from accessing and staying on the treatments they need. Currently celebrating its 15-year anniversary, the company unites the most complete view of the patient journey with purpose-built technologies to predict and resolve access challenges before they disrupt care. Our intelligent solutions combine advanced analytics, real-world data, AI, and in-line CRM capabilities to increase start and refill rates, reduce abandonment, and improve brand performance. For more information, visit www.ClaritasRx.com.

Claritas Rx named to the 2026 Inc. 5000 list for the second consecutive year. Recognition Marks the Company's Second Straight Year on the Prestigious List of America's Fastest-Growing Private Companies - and Comes as Claritas Rx Celebrates 15 Years Partnering with Life Sciences Clients SOUTH SAN FRANCISCO, Calif.-(BUSINESS WIRE)-Claritas Rx, the patient journey experts, announced today it has been named to the 2026 Inc. 5000 list for the second consecutive year, earning a place among America's fastest-growing private companies. The list is the most prestigious ranking of the nation's most successful independent and entrepreneurial businesses, recognizing companies that have achieved remarkable growth while driving innovation, creating jobs, and shaping the future of the economy. Past honorees include companies such as Microsoft, Meta, Chobani, Oracle, and Patagonia. "This year is especially meaningful, as it also marks 15 years of Claritas Rx being a trusted partner to our clients. That commitment is what has fueled our growth year after year," said Michael Fitzgibbons, CEO of Claritas Rx. Share The back-to-back honor comes as Claritas Rx marks 15 years in business, a milestone that underscores the company's long-standing role as a trusted partner to biopharma companies working to help patients start and stay on therapy. "We are honored to be named to the Inc. 5000 for the second consecutive year," said Michael Fitzgibbons, CEO of Claritas Rx. "This year is especially meaningful, as it also marks 15 years of Claritas Rx being a trusted partner to our clients. That commitment is what has fueled our growth year after year. Making this list twice in a row is a reflection of the trust our clients place in us, and of a team that stays focused on our promise: progress for every patient journey." For the full Inc. 5000 list, honoree company profiles, and a searchable database by industry and location, please visit: www.Inc.com/Inc5000. "Every company on the Inc. 5000 has a story of perseverance, smart decision making, and a refusal to sit still," says Mike Hofman, editor-in-chief of Inc. "Their growth reflects more than strong financial performance-it reflects creativity, resilience, and the customer focus required to build companies that make a lasting impact. We congratulate all honorees on this significant achievement." About Inc. Inc. is the leading media brand and playbook for the entrepreneurs and business leaders shaping its future. Through its journalism, Inc. aims to inform, educate, and elevate the profile of its community: the risk-takers, the innovators, and the ultra-driven go-getters who are creating the future of business. Inc. is published by Mansueto Ventures LLC, along with fellow leading business publication Fast Company. For more information, visit www.Inc.com. About Claritas Rx Based in South San Francisco, CA, Claritas Rx helps rare disease and specialty brands remove the barriers that keep patients from accessing and staying on the treatments they need. Currently celebrating its 15-year anniversary, the company unites the most complete view of the patient journey with purpose-built technologies to predict and resolve access challenges before they disrupt care. Its intelligent solutions combine advanced analytics, real-world data, AI, and in-line CRM capabilities to increase start and refill rates, reduce abandonment, and improve brand performance. For more information, visit www.ClaritasRx.com. More News From Claritas Rx SOUTH SAN FRANCISCO, Calif.-( BUSINESS WIRE )-Claritas Rx, the patient journey experts, today announced Consent Clearinghouse(TM), a dedicated solution for standardizing and centralizing patient consent across oncology, rare disease, and specialty biopharma. As biopharma companies navigate an increasingly complex regulatory environment, including HIPAA, GDPR, CCPA, a growing patchwork of state privacy laws, and the emerging rules governing the use of AI, managing patient consent across multiple da... SOUTH SAN FRANCISCO, Calif.-( BUSINESS WIRE )-Claritas Rx, the patient journey experts, announced new leadership appointments designed to continue growth and scale. The company has welcomed Keith Pensabene as Chief Revenue Officer (CRO) and has promoted Meghna Misra to Vice President, Product and Shelly Howard to Vice President, Customer Operations. Mr. Pensabene brings more than 25 years of executive sales and revenue leadership experience across the life sciences and enterprise software secto... SOUTH SAN FRANCISCO, Calif.-( BUSINESS WIRE )-Claritas Rx, the patient journey experts, today announced that Bhupesh Bajaj, Chief Technology Officer, has been named to the prestigious PM360 ELITE 100 list in the Data Miners category. The annual recognition highlights the most exceptional, innovative, and transformative leaders shaping the healthcare and life sciences industries today. Mr. Bajaj was recognized for his groundbreaking work redefining how data is harnessed to drive meaningful outco... Claritas Rx. Release Versions